The direct costs of treating human visceral leishmaniasis in Brazil

The direct costs of treating human visceral leishmaniasis in Brazil

Abstract INTRODUCTION: The drugs available for visceral leishmaniasis (VL) treatment in Brazil have specific characteristics in terms of operability, effectiveness, toxicity, and cost. The aim of this study was to estimate the direct costs of therapies recommended by the Ministry of Health (MH) for...

Full description

Bibliographic Details
Main Authors: Tália Santana Machado de Assis, Dian Carlos Pinheiro Rosa, Eliane de Morais Teixeira, Gláucia Cota, André Luís Ferreira Azeredo-da-Silva, Guilherme Werneck, Ana Rabello
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT)
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Therapeutics
Costs
Cost analysis
Visceral leishmaniasis
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000400478&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000400478&lng=en&tlng=en

Similar Items